SOURCE: Implant Sciences

September 12, 2011 07:00 ET

Implant Sciences Promotes Joe Laskey to Area Vice President, Asian Sales and Business Development

Marks Expansion in Significant Growth Markets of Asia and Former Soviet Republics

WILMINGTON, MA--(Marketwire - Sep 12, 2011) - Implant Sciences Corporation (OTCQB: IMSC) (PINKSHEETS: IMSC), a high technology supplier of systems and sensors for homeland security markets, today announced the promotion of Joe Laskey, formerly Managing Director of Asian Sales and Business Development, to Area Vice President and General Manager of Asian Sales and Business Development, which includes China, Russia, Japan and the 'Stans' (Kazakhstan, Uzbekistan, Turkmenistan, Tajikistan and Kyrgyzstan).

Glenn D. Bolduc, Implant Sciences' President and CEO, stated, "Joe's promotion to Area VP is in recognition of the significant market traction he has helped Implant Sciences achieve in Asia. Thanks in large part to his efforts, we expect to see continued near and long term growth in the region."

"Joe Laskey has developed strong relationships with channel partners and security organizations, building Implant Sciences into a highly respected brand in his territory," added Bruce Bower, Senior Vice President, Implant Sciences. "His keen understanding of the challenges faced by those opposing terrorism have made Joe a valued resource to his customers. We are pleased to recognize his many achievements and look forward to his continued success in growing Implant Sciences' presence in this important market."

China represents Implant Sciences' largest installed customer base with more than 800 Quantum Sniffer™ QS-H150 units shipped. The Company's new bench-top explosives trace detector, the Quantum Sniffer™ QS-B220, is now being tested in Beijing and being presented to potential customers in China.

About Implant Sciences
Implant Sciences develops, manufactures and sells sophisticated sensors and systems for Security, Safety, and Defense (SS&D) markets. The Company has developed proprietary technologies used in its commercial explosive trace detection systems which ship to a growing number of locations domestically and internationally. Implant Sciences' QS-H150 Portable Explosives Detector has been designated as Qualified Anti-Terrorism Technology by the U.S. Department of Homeland Security under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act). For further details on the Company and its products, please visit the Company's website at

Safe Harbor Statement
This press release may contain certain "forward-looking statements," as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause the Company's actual results to differ materially from the forward-looking statements. Such risks and uncertainties include, but are not limited to, the risks that our explosives detection products and technologies (including any new products we may develop) may not be accepted by governments or by other law enforcement agencies or commercial consumers of security products; economic, political and other risks associated with international sales and operations could adversely affect our sales; our future success depends in part on our ability to retain the continued services of our management, engineering and sales personnel; our business is subject to intense competition and rapid technological change; liability claims related to our products or our handling of hazardous materials could damage our reputation and have a material adverse effect on our financial results; and other risks and uncertainties described in our filings with the Securities and Exchange Commission, including our most recent Forms 10-K, 10-Q and 8-K. Such statements are based on management's current expectations and assumptions which could differ materially from the forward-looking statements.

Contact Information

  • Contact:
    Implant Sciences Corporation
    Company Contact:
    Glenn Bolduc
    Email Contact


    Investor Contact:
    Laurel Moody
    Email Contact